NR1H4 and colitis: FXR activation by a full agonist, obeticholic acid (OCA, 6-ECDCA), strongly improved clinical symptoms and histology of dextran sodium sulphate (DSS)- and trinitrobenzene sulphonic acid (TNBS)-induced colitis in wild type (WT), but not in FXR−/− mice.